Thuja Capital Healthcare Fund III

https://www.thujacapital.com

On 16 December 2021, Thuja Capital Management, an early stage life sciences investor, announces the final close of its Thuja Capital Healthcare Fund III ("Fund III") at EUR 76M. Fund III is focused on investing in early stage companies that develop novel therapeutics, medical devices (including digital health) or nutraceuticals, based in the Netherlands, Belgium or Germany. The European Investment Fund (EIF), ASR as well as several Dutch and Walloon regional investment agencies are part of a strong base of LPs supporting the fund. In addition, several universities and knowledge institutions, amongst which Sanquin, Utrecht University and UMC, Radboud UMC, Brightlands Maastricht, Delft Enterprises and KU Leuven have backed the fund. The Fund will identify early stage investment opportunities, often still at an academic project/spin-off stage, and work actively with management to develop initial preclinical proof of concept and attract follow-on investment rounds, on its way to realize meaningful healthcare impact. Fund III will build a portfolio of 10-12 investments, comprising promising and impactful Dutch, Belgian and German early-stage ventures. The fund has made three investments to date: Alesta Therapeutics (Leiden, The Netherlands), EsoBiotec (Gosselies, Belgium) and Pan Cancer T (Rotterdam, The Netherlands). *

	Start	2021-12-16 closing, final
	Group	Thuja Capital (Group)
	Industry	healthcare

	Region	Utrecht
	Country	Netherlands
	Street	40 Yalelaan
	City	3584 CM Utrecht
		Address record changed: 2021-12-23

Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	76,000,000 (fund size at final closing (2021) 2021-12-16)

		* Document for ï¿½About Sectionï¿½: Thuja Capital Management. (12/21/21). "Press Release: Thuja Announces the Final Close of Thuja Capital Healthcare Fund III at EUR 76M (USD 86M)". Utrecht.

		Record changed: 2022-01-02

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Thuja Capital (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)